Stroke Online Series (Multiple Modules)
This online series addresses aspects of stroke diagnosis, imaging, acute reperfusion therapy, neuro intensive care and general management. This online series covers ischemic stroke or transitory ischemic attack, intra-cerebral hemorrhage, subarachnoid hemorrhage, and vascular malformations such as aneurysms and arteriovenous malformations.
• How can we change screening practices to quickly identify stroke?
• What are the key aspects of acute management?
• How do I manage my stroke patient after neurointerventions?
• What are current endovascular treatments for aneurysms and subarachnoid hemorrhage?
• What are the recommendations for secondary prevention of stroke?
Neuroscience Center Physicians and Nurses: These online courses meet continuing medical education requirements for recredentialing for Baptist Health Neuroscience Center.
Instructions: Select topic below to view additional details and to enroll.
Neurologists, Neuro-oncologists, Neuroradiologists, Neurointensivists, Neurosurgeons, Radiologists, Vascular Surgeons, Cardiologists, Critical Care Physicians, Diagnostic Radiologists, Emergency Medicine Physicians, Family Physicians, General Internists, Hospitalists, Internists, Interventional Neuroradiologists, Physician Assistants, Fellows, Nurses, Technicians involved with stroke care and Stroke Educators.
See individual module pages for faculty titles and disclosure information.
MIAMI NEURO SYMPOSIUM PLANNERS
Kevin Abrams, M.D., has disclosed that he serves as a consultant to Keystone Heart. Dr. Abrams has indicated that his presentation will not include discussion of off-label or unapproved usage.
Guilherme Dabus, M.D., has disclosed that he serves as a consultant to and is a member of the speaker’s bureaus for Medtronic, Microvention and Penumbra; also, Dr. Dabus is a stock shareholder in Surpass/Stryker, Medtronic/Medina Medical, Elum, InNeuroCo and Three Rivers. Dr. Dabus has also disclosed that his presentations will include discussion of off-label or unapproved usage.
Italo Linfante, M.D., has disclosed that he serves as a consultant to Covidien/Medtronic, Stryker and Penumbra, and that he is a stock shareholder in InNeuroCo. Dr. Linfante has also disclosed that his presentations will include discussion of off-label or unapproved usage.
Nothing to Disclose
Felipe De Los Rios La Rosa, M.D., Karel Fuentes, M.D. and Sergio Gonzalez-Arias, M.D. have indicated that neither they nor their spouses/partners have relevant financial relationships with commercial interest companies, and they will not include off-label or unapproved product usage in their presentations or discussions:
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
See individual course pages for applicable credits and accreditations.